Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Antithrombin III. Key factor in extracorporeal circulation.

¹Istituto Policlinico S. Donato, Department of Cardiothoracic Anesthesia, San Donato Milanese (Milan), Italy.

Minerva Anestesiologica

|May 25, 2002

Summary

Antithrombin III, crucial for preventing clots during heart surgery, is consumed during cardiopulmonary bypass. This depletion can lead to a prothrombotic state, increasing risks for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neurocognitive function in procedures correcting severe aortic valve stenosis: patterns and determinants.

Frontiers in cardiovascular medicine·2024

Same author

Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?

Journal of biological regulators and homeostatic agents·2021

Same author

A European consensus statement on the use of four-factor prothrombin complex concentrate for cardiac and non-cardiac surgical patients.

Anaesthesia·2020

Same author

The role of fibrinogen and fibrinogen concentrate in cardiac surgery: an international consensus statement from the Haemostasis and Transfusion Scientific Subcommittee of the European Association of Cardiothoracic Anaesthesiology.

Anaesthesia·2019

Same author

Body mass index stratification in hospitalized Italian adults with congenital heart disease in relation to complexity, diagnosis, sex and age.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2019

Same author

Is there a role for von Willebrand factor/factor VIII concentrate supplementation in complex congenital heart surgery?

Journal of thrombosis and haemostasis : JTH·2018

Area of Science:

Cardiovascular Surgery
Hematology
Biochemistry

Background:

Antithrombin III (ATIII) is a natural inhibitor of thrombin.
Heparin enhances ATIII's anticoagulant activity, preventing clot formation in cardiopulmonary bypass (CPB).

Purpose of the Study:

To investigate the role and consumption of Antithrombin III during cardiac operations involving CPB.
To elucidate the implications of ATIII depletion on thrombotic risk and heparin efficacy post-CPB.

Main Methods:

Review of Antithrombin III's function in the context of CPB.
Analysis of ATIII consumption as a 'suicide substrate' during CPB.
Examination of thrombin generation and ATIII-thrombin interaction dynamics.

Main Results:

Related Experiment Videos

ATIII is consumed during CPB, leading to potential imbalance with increased thrombin levels.
Pre-existing low ATIII levels in heparin-treated patients can cause heparin resistance.
This imbalance increases the risk of postoperative thrombotic complications.

Conclusions:

Antithrombin III depletion during CPB poses a significant prothrombotic risk.
Monitoring and potentially supplementing ATIII may be crucial for patients undergoing CPB.
The anti-inflammatory role of ATIII during CPB warrants further investigation.